InvestorsHub Logo
Followers 85
Posts 314
Boards Moderated 0
Alias Born 06/20/2020

Re: positivealpha post# 27124

Saturday, 10/03/2020 10:18:33 AM

Saturday, October 03, 2020 10:18:33 AM

Post# of 198663
PLEASE STICKY: They are getting current and only have a few quarters to update (the last filing was in 2018 or '19) so not much ground to make up.

The risk/reward ratio here is actually quite appealing given the LATE STAGES OF DEVELOPMENT both companies are in with respect to their potential HIV cures . . .

Throw in the fact that BioClonetics are legitimate pioneers in the discovery and development of MONOCLONAL ANTIBODIES and you have a perfect storm. The 2 studies which Dr. Fauci used to tout MONOCLONAL ANTIBODIES as "the most promising" potential cure for Covid came out just LAST WEEK. This is fresh. Gotta stay ahead of the game.

Trump is taking MONOCLONAL ANTIBODIES shows that this is the best possible treatment at this moment in time and funding for advacements/development will be flowing in. I read a ton of academic literature last night on MONOCLONAL ANTIBODIES in which the Cotropia Bros are cited as authorities. They will be involved with developing a Covid cure utilizing MONOCLONAL ANTIBODIES without a doubt. Stay ahead!

Hedge Funds look for 30-100 Baggers. At these levels, the risk/reward ratio is there for someone willing to do the research.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News